FDA PMA FDA Class 3 Approved 🇺🇸 United States

Excimer Laser System

PMA: P970043 · Supplement: S002 · Decision Dec 3, 1999
Classifications
1
FEI Numbers
9
Registration Numbers
10

Basic Information

Device Name
Excimer Laser System
Trade Name
LADAR VISION EXCIMER LASER SYSTEM
PMA Number
P970043
Supplement Number
S002
Device Class
FDA Class 3
Product Code
LZS
Generic Name
Excimer laser system
Medical Specialty
Unknown
Advisory Committee
Ophthalmic
Decision
Approved
Decision Code
APPR
Decision Date
December 3, 1999
Date Received
March 3, 1999
Supplement Type
Normal 180 Day Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

Approval to modify the current labeling by 1)updating the clinical results with 12-month data; 2)presenting the 12-month data stratified into three groups (low myopia, low myopia with astigmatism, and high myopia with and without astigmatism) based on preoperative refractive error, and 3) including new contrast sensitivity claims based on a contrast sensitivity study of 284 pts. Other modifications to the labeling include editorial changes, the addition of new data tables reformatted to reflect the revised stratification of data, and the inclusion of a revised contrast sensitivity labeling statement to read: "In a constrast sensitivity study designed to assess theeffects of LADARVision surgery on how well patients can see in conditions such as very dim light, rain, snow, fog or glare from bright lights at night, the percentages of patients showing clinically significant losses were 10.6% at 6 months and 6.6% at 12 months after surgery, and the percentages of patients showing clinically significant improvements were 5.9% at 6 months and 3.3% at 12 months after surgery."

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LZS Excimer Laser System